Last reviewed · How we verify

NCT02638675

Financial Health Incentives to Promote Physical Activity Among Hospital Employees: A Randomized Control Trial

Completed NA Last updated 11 May 2018
What this trial tests

NA trial testing Wellness program in Physically Inactive Hospital Employees in 99 participants. Completed in 30 November 2017.

Timeline
6 February 2017
Primary endpoint
30 November 2017
30 November 2017

Quick facts

Lead sponsorUniversity of Toronto
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment99
Start date6 February 2017
Primary completion30 November 2017
Estimated completion30 November 2017
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Toronto

Who can join

18 and older, any sex, with Physically Inactive Hospital Employees. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this randomized control trial is to examine whether incentives-for-steps (i.e. $1 per day step count goals are reached) increase daily step counts among physically inactive hospital employees.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Examining Incentives to Promote Physical Activity Maintenance Among Hospital Employees Not Achieving 10,000 Daily Steps: A Web-Based Randomized Controlled Trial Protocol.
    Mitchell M, White L, Oh P, Kwan M, et al · · 2016 · cited 4× · PMID 27956377 · DOI 10.2196/resprot.6285

Verify or expand the search:

Other trials of Wellness program

Trials testing the same drug.

Other University of Toronto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02638675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing